In The News

Georgia Research Alliance and Georgia Tech sources also provided funding for a total investment of $23 million. The center also plans to seek funding from federal agencies, clinical research organizations and other sources.

In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard Stem Cell Institute and biotech Semma Therapeutics to make personalized cell-based therapies and organize clinical trials.

The work of the new Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) is expected to provide standardized production and quality testing of these living cells, similar to that which already exists for drug-based pharmaceuticals.

A $15.7 million grant from the Atlanta-based Marcus Foundation has helped launch a new Georgia Institute of Technology research center that will develop processes and techniques for ensuring the consistent, low-cost, large-scale manufacture of high-qualit